Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.

Cuenco KT, Green RC, Zhang J, Lunetta K, Erlich PM, Cupples LA, Farrer LA, DeCarli C; MIRAGE Study Group..

J Neuroimaging. 2008 Jul;18(3):268-75. doi: 10.1111/j.1552-6569.2007.00191.x.

2.

Heritability of magnetic resonance imaging (MRI) traits in Alzheimer disease cases and their siblings in the MIRAGE study.

Lunetta KL, Erlich PM, Cuenco KT, Cupples LA, Green RC, Farrer LA, Decarli C; MIRAGE Study Group..

Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):85-91.

PMID:
17545732
3.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
4.

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM.

JAMA Neurol. 2014 Jul 1;71(7):855-62. doi: 10.1001/jamaneurol.2014.754.

PMID:
24818585
5.

Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease.

T Cuenco K, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, Green RC, St George-Hyslop PH, Chui H, DeCarli C, Farrer LA; MIRAGE Study Group..

Arch Neurol. 2008 Dec;65(12):1640-8. doi: 10.1001/archneur.65.12.1640.

6.

The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities.

Høgh P, Garde E, Mortensen EL, Jørgensen OS, Krabbe K, Waldemar G.

Acta Neurol Scand. 2007 Apr;115(4):248-53.

PMID:
17376122
7.

Multiple loci influencing hippocampal degeneration identified by genome scan.

Melville SA, Buros J, Parrado AR, Vardarajan B, Logue MW, Shen L, Risacher SL, Kim S, Jun G, DeCarli C, Lunetta KL, Baldwin CT, Saykin AJ, Farrer LA; Alzheimer's Disease Neuroimaging Initiative..

Ann Neurol. 2012 Jul;72(1):65-75. doi: 10.1002/ana.23644. Epub 2012 Jun 28.

8.

Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.

Jiang S, Yang W, Qiu Y, Chen HZ; Alzheimer's Disease Neuroimaging Initiative (ADNI)..

Curr Alzheimer Res. 2015;12(3):218-27.

PMID:
25731621
9.

Head injury and the risk of AD in the MIRAGE study.

Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, Johnson K, Go RC, Growdon JH, Haines JL, Kukull WA, Farrer LA.

Neurology. 2000 Mar 28;54(6):1316-23.

PMID:
10746604
10.

Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Debette S, Wolf PA, Beiser A, Au R, Himali JJ, Pikula A, Auerbach S, Decarli C, Seshadri S.

Neurology. 2009 Dec 15;73(24):2071-8. doi: 10.1212/WNL.0b013e3181c67833. Epub 2009 Dec 9.

11.

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Burns JM.

Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.

12.

Apolipoprotein E4 and brain white matter integrity in Alzheimer's disease: tract-based spatial statistics study under 3-Tesla MRI.

Bagepally BS, Halahalli HN, John JP, Kota L, Purushottam M, Mukherjee O, Sivakumar PT, Bharath S, Jain S, Varghese M.

Neurodegener Dis. 2012;10(1-4):145-8. doi: 10.1159/000334761. Epub 2012 Jan 21.

PMID:
22269984
13.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
14.

[Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].

Li J, Kuang WH, Li J, Wang X, Huang MS, Wu DP.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jan;36(1):50-2. Chinese.

PMID:
15702779
15.

Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J.

Am J Psychiatry. 2007 Jun;164(6):916-21.

PMID:
17541051
16.

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, Hermann BP, Koscik R, Jonaitis E, Rowley HA, Carlsson CM, Asthana S, Sager MA, Johnson SC.

Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.

17.

Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.

Pievani M, Rasser PE, Galluzzi S, Benussi L, Ghidoni R, Sabattoli F, Bonetti M, Binetti G, Thompson PM, Frisoni GB.

Neuroimage. 2009 May 1;45(4):1090-8. doi: 10.1016/j.neuroimage.2009.01.009. Epub 2009 Jan 21.

18.

Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families.

Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA; MIRAGE Study Group..

Neurobiol Aging. 2011 Feb;32(2):249-56. doi: 10.1016/j.neurobiolaging.2009.02.014. Epub 2009 Mar 27.

19.

Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.

Gutiérrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, Ourselin S, Schott JM, Fox NC, Barnes J.

Dement Geriatr Cogn Disord. 2009;28(5):476-85. doi: 10.1159/000258100. Epub 2009 Nov 26.

PMID:
19940480
20.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

Supplemental Content

Support Center